Bellevue Life Sciences Acquisition Corp.
|
(Name of Issuer)
|
Common Stock, par value $0.0001 per share
|
(Title of Class of Securities)
|
079174108
|
(CUSIP Number)
|
December 31, 2023
|
(Date of Event Which Requires Filing of this Statement)
|
CUSIP No. 079174108
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Bellevue Global Life Science Investors, LLC
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
State of Delaware
|
|
|
|||
|
|
||||
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
2,035,000 (1)
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
2,035,000 (1)
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
2,035,000
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
36.2% (2)
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
OO
|
|
|
|||
|
|
CUSIP No. 079174108
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Bellevue Capital Management LLC
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
State of Washington
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
2,035,000 (1)
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
2,035,000 (1)
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
2,035,000
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
36.2% (2)
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
OO
|
|
|
|||
|
|
CUSIP No. 079174108
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Kuk Hyoun Hwang
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Republic of Korea
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
2,035,000 (1)
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
2,035,000 (1)
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
2,035,000
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
36.2% (2)
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
IN
|
|
|
|||
|
|
CUSIP No. 079174108
|
|
Item 1
(a) Name of Issuer: Bellevue Life Sciences Acquisition Corp., a Delaware corporation (the “Company”)
(b) Address of Issuer’s Principal Executive Offices: 10900 NE 4th Street, Suite 2300, Bellevue, WA 98004
|
Item 2
(a) Name of Person Filing:
(1) Bellevue Global Life Science Investors, LLC (the "Sponsor")
(2) Bellevue Capital Management LLC ("Bellevue Capital")
(3) Kuk Hyoun Hwang
(b) Address of Principal Business Office, or if None, Residence:
The address for these entities and this individual is:
C/O Bellevue Life Sciences Acquisition Corp.
10900 NE 4th Street
Suite 2300
Bellevue, WA 98004
(c) Citizenship:
(1) Sponsor – State of Delaware
(2) Bellevue Capital - State of Washington
(3) Kuk Hyoun Hwang – Republic of Korea
(d) Title of Class of Securities: Common Stock, par value $0.0001 per share
(e) CUSIP Number: 079174108
|
Item 3.
|
Not Applicable
|
|||
|
Item 4.
|
Ownership.
|
Item 5.
|
Ownership of Five Percent or Less of a Class. Not Applicable
|
Item 6.
|
Ownership of More Than Five Percent on Behalf of Another Person. Not Applicable
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable
|
Item 8.
|
Identification and Classification of Members of the Group. Not Applicable
|
Item 9.
|
Notice of Dissolution of Group. Not Applicable
|
Item 10.
|
Certifications. Not Applicable
|
CUSIP No. 079174108
|
|
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
|
BELLEVUE GLOBAL LIFE SCIENCE INVESTORS, LLC
|
||
|
|
||
February 8, 2024 |
By: |
Bellevue Capital Management LLC, Its Manager
|
|
By: |
/s/ Kuk Hyoun Hwang | ||
Kuk Hyoun Hwang, Managing Member
of Bellevue Capital Management LLC
|
|
BELLEVUE CAPITAL MANAGEMENT LLC
|
||
|
|
||
February 8, 2024 |
By: |
/s/ Kuk Hyoun Hwang | |
Kuk Hyoun Hwang, Managing Member
|
|
KUK HYOUN HWANG
|
|
February 8, 2024 |
/s/ Kuk Hyoun Hwang | |
Kuk Hyoun Hwang
|
|
BELLEVUE GLOBAL LIFE SCIENCE INVESTORS, LLC
|
||
|
|
||
February 8, 2024 |
By: |
Bellevue Capital Management LLC, Its Manager
|
|
By: |
/s/ Kuk Hyoun Hwang | ||
Kuk Hyoun Hwang, Managing Member
of Bellevue Capital Management LLC
|
|
BELLEVUE CAPITAL MANAGEMENT LLC
|
||
|
|
||
February 8, 2024 |
By: |
/s/ Kuk Hyoun Hwang | |
Kuk Hyoun Hwang, Managing Member
|
|
KUK HYOUN HWANG
|
|
February 8, 2024 |
/s/ Kuk Hyoun Hwang | |
Kuk Hyoun Hwang
|